Saturday 17 October 2026 Export VRTX’s income statement to Excel — free account

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $12.0 billion, up 8.90% from fiscal 2024. In the quarter to June 2026, revenue grew 12.5%, EPS grew 7.96% and free cash flow grew 9.25%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years.

499.39 9.36 −1.84%

Follow VRTX

Alert me

Market cap: $129.0B
P/E: 28.8×
Fwd P/E: 25.5×
Dividend yield: —
F-score: 8/9
Altman Z: 12.06
Beneish M: −2.17
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	27.33	29.31	26.25	28.66
P/S ratio Full definition →		8.54	9.66	9.29	10.01
P/FCF ratio Full definition →		30.00	36.30	30.58	33.20
P/Operating CF Full definition →		80.64	232.78	79.45	111.98
P/B ratio Full definition →		5.78	6.21	5.86	6.22
Price to Tangible BV Full definition →		6.34	6.76	6.35	6.72
EV/Sales Full definition →		8.04	9.14	8.73	9.42
EV/EBITDA Full definition →		22.47	25.03	21.77	23.72
EV/Operating CF Full definition →		25.34	30.22	25.15	27.62
EV/FCF Full definition →		28.24	34.36	28.74	31.24
Quick Ratio Full definition →		1.84	2.24	2.38	2.54
Current Ratio Full definition →		2.36	2.90	3.02	3.19
Net Debt/EBITDA Full definition →		(5.07)	(5.24)	(6.07)	(6.02)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.50	0.50	0.50	0.49
Operating CF/Net income Full definition →		1.15	0.42	1.38	1.02
Capex/Depreciation Full definition →		(1.89)	(2.68)	(2.39)	(1.99)
Interest Coverage Full definition →		359.45	120.59	—	—
Research and Development Expense of Revenue Full definition →		31.78%	30.52%	32.19%	29.81%
Selling, General and Administrative Expense of Revenue Full definition →		14.47%	15.27%	16.53%	17.46%
Intangible Assets out of Total Assets Full definition →		0.06	0.06	0.06	0.05
Share Based Compensation of Revenue Full definition →		6.34%	4.94%	5.57%	5.11%
Graham Net Nets Full definition →		0.03	0.04	0.04	0.04
Graham Number Full definition →		147.81	159.40	170.77	176.41
Earnings Yield Full definition →		3.66%	3.41%	3.81%	3.49%
Free Cash Flow Yield Full definition →		3.33%	2.76%	3.27%	3.01%
Revenue per Share Full definition →		12.04	12.48	11.75	13.14
Operating CF per Share Full definition →		4.86	1.95	5.62	4.44
Capex per Share Full definition →		(0.40)	(0.58)	(0.52)	(0.44)
Free Cash Flow per Share Full definition →		4.46	1.36	5.10	3.99
Cash per Share Full definition →		24.60	25.84	28.52	30.95
Shareholders Equity per Share Full definition →		67.76	73.00	76.20	79.81
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		67.76	73.00	76.20	79.81
Free Cash Flow Full definition →		1,139.60	348.60	1,294.70	1,013.20
Working Capital Full definition →		6,094.30	7,339.80	7,849.70	8,605.80
Capital Expenditures Full definition →		(101.80)	(149.40)	(133.40)	(112.20)
Net Current Asset Value Full definition →		3,026.10	4,223.80	4,607.80	5,368.30
EV/EBIT Full definition →		23.60	26.29	22.78	24.82
Capex to Sales Full definition →		0.03	0.05	0.04	0.03
Price to Operating Income Full definition →		25.07	27.78	24.24	26.38
Other line items
Average Receivables Full definition →		1,848.50	1,831.10	1,900.60	2,013.90
Average Payables Full definition →		408.05	437.35	467.15	435.90
Average Inventory Full definition →		1,353.30	1,446.10	1,563.20	1,632.20
Average Assets Full definition →		23,551.25	24,088.10	24,682.45	25,730.00
Average Common Equity Full definition →		16,474.85	17,537.70	17,929.10	18,711.65

Show all line items

Columns are period end dates

Stockrow Weekly